Advances in clinical treatment of MALT lymphoma
10.3760/cma.j.issn.1004-4221.2017.08.023
- VernacularTitle:黏膜相关淋巴组织淋巴瘤临床治疗进展
- Author:
Ke LIU
;
Suyu ZHU
- Keywords:
Lymphoma;
mucosa-associated lymphoid tissue;
Helicobacter pylori;
Radiotherapy
- From:
Chinese Journal of Radiation Oncology
2017;26(8):956-960
- CountryChina
- Language:Chinese
-
Abstract:
Mucosa-associated lymphoid tissue (MALT) lymphoma often occurs in the stomach as well as the head and neck.This disease has characteristics of multi-site dissemination and indolent development,and about 80% of MALT lymphoma patients are in early stage.Helicobacter pylori (Hp) eradication is the main method for treating early-stage Hp-positive gastric MALT lymphoma.For patients with other types of early-stage MALT lymphoma and those with gastric MALT lymphoma who failed Hp eradication therapy,radiotherapy has a good clinical effect.In recent years,radiotherapy target volume has changed from the involved field to the involved site,and the dose has been decreased.This article provides a review of the above aspects.
